ALK/EGFR-IN-2 is a potent dual inhibitor targeting ALK and EGFR, promoting apoptosis and G0/G1 cell cycle arrest in cancer cells. It effectively suppresses proliferation in H1975, PC9, and Baf3-EML4-ALK cancer cell lines, with IC50s of 0.0034, 0.0065, and 0.0018 µM, respectively [1].
Molecular Weight:
572.12
CAS Number:
[2730432-75-2]
Formula:
C27H34ClN7O3S
Target:
ALK|||Others
T79393
* VAT and and shipping costs not included. Errors and price changes excepted
